Cancer risk in dialyzed patients with and without diabetes.


Journal

Cancer epidemiology
ISSN: 1877-783X
Titre abrégé: Cancer Epidemiol
Pays: Netherlands
ID NLM: 101508793

Informations de publication

Date de publication:
04 2020
Historique:
received: 13 12 2019
revised: 14 02 2020
accepted: 17 02 2020
pubmed: 4 3 2020
medline: 29 8 2020
entrez: 4 3 2020
Statut: ppublish

Résumé

The risk of cancer is higher in patients with renal diseases and diabetes compared with the general population. The aim of this study was to assess in dialyzed patients, the association between diabetes and the risk to develop a cancer after dialysis start. All patients who started dialysis in the French region of Poitou-Charentes between 2008 and 2015 were included. Their baseline characteristics were extracted from the French Renal Epidemiology and Information Network and were linked to data relative to cancer occurrence from the Poitou-Charentes General Cancer Registry using a procedure developed by the INSHARE platform. The association between diabetes and the risk of cancer was assessed using the Fine & Gray model that takes into account the competing risk of death. Among the 1634 patients included, 591 (36.2 %) had diabetes and 91 (5.6 %) patients developed a cancer (n = 24 before or at dialysis start, and n = 67 after dialysis start). The risk to develop a cancer after dialysis initiation was lower in dialyzed patients with diabetes than without diabetes (SHR = 0.54; 95 %CI: 0.32-0.91). Moreover, compared with the general population, the cancer risk was higher in dialyzed patients without diabetes, but not in those with diabetes. The risk of developing a cancer in the region of Poitou-Charentes is higher in dialyzed patients without diabetes than with diabetes.

Sections du résumé

BACKGROUND
The risk of cancer is higher in patients with renal diseases and diabetes compared with the general population. The aim of this study was to assess in dialyzed patients, the association between diabetes and the risk to develop a cancer after dialysis start.
METHODS
All patients who started dialysis in the French region of Poitou-Charentes between 2008 and 2015 were included. Their baseline characteristics were extracted from the French Renal Epidemiology and Information Network and were linked to data relative to cancer occurrence from the Poitou-Charentes General Cancer Registry using a procedure developed by the INSHARE platform. The association between diabetes and the risk of cancer was assessed using the Fine & Gray model that takes into account the competing risk of death.
RESULTS
Among the 1634 patients included, 591 (36.2 %) had diabetes and 91 (5.6 %) patients developed a cancer (n = 24 before or at dialysis start, and n = 67 after dialysis start). The risk to develop a cancer after dialysis initiation was lower in dialyzed patients with diabetes than without diabetes (SHR = 0.54; 95 %CI: 0.32-0.91). Moreover, compared with the general population, the cancer risk was higher in dialyzed patients without diabetes, but not in those with diabetes.
CONCLUSION
The risk of developing a cancer in the region of Poitou-Charentes is higher in dialyzed patients without diabetes than with diabetes.

Identifiants

pubmed: 32126508
pii: S1877-7821(20)30023-0
doi: 10.1016/j.canep.2020.101689
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101689

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All authors declare that there is no conflict of interest regarding the publication of this article.

Auteurs

Adélaïde Pladys (A)

Univ Rennes, EHESP, REPERES (Recherche en pharmaco-épidémiologie et recours aux soins) - EA 7449, F-35000 Rennes, France.

Gautier Defossez (G)

Poitou-Charentes General Cancer Registry, Poitiers University Hospital, University of Poitiers, Poitiers, France; INSERM, CIC1402, Poitiers, France.

Pierre Lemordant (P)

Univ Rennes, CHU Rennes, INSERM, LTSI - UMR 1099, F-35000 Rennes, France.

Mathilde Lassalle (M)

Renal Epidemiology and Information Network (REIN), Biomedicine Agency, La Plaine Saint-Denis, France.

Pierre Ingrand (P)

Poitou-Charentes General Cancer Registry, Poitiers University Hospital, University of Poitiers, Poitiers, France; INSERM, CIC1402, Poitiers, France.

Christian Jacquelinet (C)

Renal Epidemiology and Information Network (REIN), Biomedicine Agency, La Plaine Saint-Denis, France; CESP Centre for Research in Epidemiology and Population Health, Inserm UMRS 1018, Univ Versailles-Saint Quentin, Univ Paris-Saclay, Univ Paris Sud, Villejuif, France. Electronic address: christian.jacquelinet@biomedecine.fr.

Christine Riou (C)

Univ Rennes, CHU Rennes, INSERM, LTSI - UMR 1099, F-35000 Rennes, France.

Guillaume Bouzillé (G)

Univ Rennes, CHU Rennes, INSERM, LTSI - UMR 1099, F-35000 Rennes, France.

Pascal Van Hille (P)

Univ Rennes, CHU Rennes, INSERM, LTSI - UMR 1099, F-35000 Rennes, France.

Cécile Vigneau (C)

University of Rennes 1, INSERM U1085-IRSET, Rennes, France; CHU Pontchaillou, Department of Nephrology, Rennes, France.

Marc Cuggia (M)

Univ Rennes, CHU Rennes, INSERM, LTSI - UMR 1099, F-35000 Rennes, France.

Sahar Bayat (S)

Univ Rennes, EHESP, REPERES (Recherche en pharmaco-épidémiologie et recours aux soins) - EA 7449, F-35000 Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH